Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KIAA1549-like protein (KIAA1549L) is a human protein encoded by the KIAA1549L gene (also known as C11orf41 or C11orf69), located on chromosome 11p13[2]. It is comprised of 1849 amino acids and contains highly conserved regions, but its exact cellular function has not been established[1][2]. The only known feature by motif prediction is a potential transmembrane domain; however, its physiological relevance remains unclear[1]. KIAA1549L is preferentially expressed in the human cerebral cortex and localizes to both the nucleus and cytoplasmic vesicles[1]. Notably, KIAA1549L has been identified as a fusion partner in rare cases of leukemia, such as pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL) in which it forms an oncogenic fusion with PAX5, and a reported fusion with RUNX1 in acute myeloid leukemia[1]. The fusion events suggest a possible but uncharacterized contribution to cancer, while the normal biological function, potential as a drug target, and clinical implications of KIAA1549L remain undetermined[1][2].
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on KIAA1549-like protein (KIAA1549L).